Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin Extract as Adjuvant Therapy for Typhoid Carriers
NCT07908030Phase 2Not yet recruiting
- Sponsor
- Universitas Sebelas Maret
- Start
- Nov 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in typhoid fever (2 arms), sponsored by Universitas Sebelas Maret. Primary endpoint: Proportion of participants with negative Salmonella Typhi culture. Planned start Nov 2026; status: not yet recruiting.
02
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT07908030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07908030.